The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.

The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.

Pharmaceutical composition and delivery system for prevention and treatment of candidiasis featuring a composition of thymol oil, eugenol oil, and/or carvacrol oil encapsulated in microcapsules, with the microcapsules embedded in a medicated microbial cellulosic matrix. The cellulosic matrix may in turn be embedded in or form a conveyance material, such as a panty liner, a mucoadhesive patch, or chewing gum.

Pharmaceutical composition and delivery system for prevention and treatment of candidiasis featuring a composition of thymol oil, eugenol oil, and/or carvacrol oil encapsulated in microcapsules, with the microcapsules embedded in a medicated microbial cellulosic matrix. The cellulosic matrix may in turn be embedded in or form a conveyance material, such as a panty liner, a mucoadhesive patch, or chewing gum.

Pharmaceutical composition and delivery system for prevention and treatment of candidiasis featuring a composition of thymol oil, eugenol oil, and/or carvacrol oil encapsulated in microcapsules, with the microcapsules embedded in a medicated microbial cellulosic matrix. The cellulosic matrix may in turn be embedded in or form a conveyance material, such as a panty liner, a mucoadhesive patch, or chewing gum.

The present invention includes DNP derivatives that are useful for preventing or treating a metabolic disease or disorder in a subject in need thereof. In certain embodiments, the subject is further administered at least one additional therapeutic agent.

The present invention includes DNP derivatives that are useful for preventing or treating a metabolic disease or disorder in a subject in need thereof. In certain embodiments, the subject is further administered at least one additional therapeutic agent.

Provided are methods and compositions for reducing a throat irritation caused by inhaling vapors or particles of at least one material selected from the group consisting of cannabis, cannabinoids, tobaccO, a herb or combinations thereof, the method comprising administering to a subject in need thereof at least one transient receptor potential (TRP) channel modulator prior to or simultaneously with said inhaling said vapors or particles of said at least one material. Further provided are methods and compositions comprising at least one TRP channel agonist, and/or at least one TRP channel partial agonist for treating pain-selective analgesia via TRP channels; methods for treating local pain; methods for treating migraine and symptoms thereof; and methods for treating osteoporosis and symptoms thereof.

Provided are methods and compositions for reducing a throat irritation caused by inhaling vapors or particles of at least one material selected from the group consisting of cannabis, cannabinoids, tobaccO, a herb or combinations thereof, the method comprising administering to a subject in need thereof at least one transient receptor potential (TRP) channel modulator prior to or simultaneously with said inhaling said vapors or particles of said at least one material. Further provided are methods and compositions comprising at least one TRP channel agonist, and/or at least one TRP channel partial agonist for treating pain-selective analgesia via TRP channels; methods for treating local pain; methods for treating migraine and symptoms thereof; and methods for treating osteoporosis and symptoms thereof.

The invention provides safe and efficacious treatments for Female Sexual Disorders, genitopelvic pain/penetration disorders; vulvovaginal atrophy, vestibulodynia, dyspareunia, sexual interest/arousal disorder, low female libido, and female orgasmic disorder.